Literature DB >> 6105854

Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities.

P B Timmermans, H Y Kwa, F K Ali, P A van Zwieten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6105854

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  12 in total

1.  Clinical pharmacological studies with doxazosin.

Authors:  H L Elliott; P A Meredith; J Vincent; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.

Authors:  C A Hamilton; J L Reid; J Vincent
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

3.  Pharmacological activity of ACC-7513, a selective alpha-adrenoceptor and 5-hydroxytryptamine receptor blocking agent.

Authors:  W G Anderson; S T Kam
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

4.  A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

Authors:  H L Elliott; P A Meredith; D J Sumner; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

5.  Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin.

Authors:  O A Downing; K A Wilson; V G Wilson
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

6.  Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.

Authors:  J Vincent; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

7.  A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.

Authors:  M H Frick; P Halttunen; P Himanen; M Huttunen; P Pörsti; T Pitkäjärvi; L Pöyhönen; M L Pyykönen; P Reinikainen; P Salmela
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.

Authors:  P Lund-Johansen; P Omvik; H Haugland
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

9.  The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

Authors:  B Kaye; N J Cussans; J K Faulkner; D A Stopher; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

10.  The pharmacokinetics and pharmacodynamics of doxazosin compared with atenolol during long-term double-blind treatment.

Authors:  J K Faulkner; P Himanen; U Karjalainen; M Saraste
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.